New Delhi, India: India-based biotechnology company, Bharat Biotech, on Friday (Aug 5) informed that Japan has approved the Covaxin booster dose for travellers. In the tweet, Bharat Biotech said “We are proud to announce, that Japan has approved Covaxin booster dose for travellers. Another global recognition of the effectiveness of our universal Covid vaccine.”
The Japanese Government issued an advisory for the Quarantine period after entering Japan.
(1) Travelers who are entering or returning to Japan from countries/regions categorized as “RED” in border control measures(28) and who have not had three doses of a COVID-19 vaccination will be required to quarantine for three days at accommodations designated by a quarantine station. If the results of a test taken at the accommodations are negative, they will not be required to
quarantine after leaving the facility.
(2) Travelers who are entering or returning to Japan from countries/regions categorized as “RED” in border control measures(28) and who have a certificate confirming they have received three vaccination doses will be required to quarantine at home/accommodations of their choice for five days, in principle. However, if they take a self-test after three days after entering Japan and submit a negative result to the Ministry of Health, Labour and Welfare (Health Monitoring Center for Overseas Entrants, or HCO) where its status is confirmed, they will not be required to remain in quarantine after that.
(3) Travelers who are entering or returning to Japan from countries/regions categorized as “YELLOW” in border control measures(28) and have not received three vaccination doses will be required to quarantine at home/accommodations of their choice for five days, in principle. However, if they take a self-test after three days after entering Japan and submit a negative result to the Ministry of Health, Labour and Welfare (Health Monitoring Center for Overseas Entrants, or HCO) where its status is confirmed, they will not be required to remain in quarantine after that.
